JPMorgan Chase & Co. Increases SpringWorks Therapeutics (NASDAQ:SWTX) Price Target to $74.00
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) had its price target hoisted by investment analysts at JPMorgan Chase & Co. from $73.00 to $74.00 in a note issued to investors on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside […]
More Stories
Serve Robotics (NASDAQ:SERV) Trading Up 8.1% – Still a Buy?
Serve Robotics Inc. (NASDAQ:SERV – Get Free Report) shares traded up 8.1% during mid-day trading on Monday . The company...
QuantumScape (NYSE:QS) Stock Price Up 11.8% – Should You Buy?
QuantumScape Co. (NYSE:QS – Get Free Report) traded up 11.8% on Monday . The company traded as high as $6.84...
UiPath (NYSE:PATH) Stock Price Up 8.2% – What’s Next?
UiPath Inc. (NYSE:PATH – Get Free Report) shot up 8.2% during mid-day trading on Monday . The stock traded as...
UnitedHealth Group (NYSE:UNH) Trading 0.6% Higher – Time to Buy?
UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) was up 0.6% during mid-day trading on Monday . The company traded...
RUA Life Sciences (LON:RUA) Trading 9.2% Higher – Time to Buy?
RUA Life Sciences plc (LON:RUA – Get Free Report)’s share price was up 9.2% on Monday . The company traded...
Vanguard S&P Mid-Cap 400 Growth ETF (NYSEARCA:IVOG) Sees Strong Trading Volume – Here’s What Happened
Vanguard S&P Mid-Cap 400 Growth ETF (NYSEARCA:IVOG – Get Free Report) saw an uptick in trading volume on Monday ....